Researchers at University of California San Diego School of Medicine describe a new approach that uses machine learning to hunt for disease targets and then predicts whether a drug is likely to receive FDA approval.
Related Articles

News
Not So Great Expectations: Pain in HIV Related to Brain’s Expectations of Relief
November 4, 2021
sandiegobiotech
News
Comments Off on Not So Great Expectations: Pain in HIV Related to Brain’s Expectations of Relief
Neuroimaging study reveals potential brain mechanism underlying chronic neuropathic pain in individuals with HIV. Findings may guide new clinical treatments targeting patients’ expectations for pain relief. Click here to view original post… […]

Industry News
Data Science Freshman Makes His First Cloud
December 14, 2018
sandiegobiotech
Industry News, News
Comments Off on Data Science Freshman Makes His First Cloud
Since coding is fun to freshman Yuan Gao, creating his first word cloud from the Facebook page of Hal?c?o?lu Data Science Institute at UC San Diego was basically entertainment. He created the montage-style graph… […]

News
Engineer Earns Presidential Award for Improving Underrepresented Student Access to STEM Experiences
August 6, 2020
sandiegobiotech
News, UCSD News
Comments Off on Engineer Earns Presidential Award for Improving Underrepresented Student Access to STEM Experiences
Olivia Graeve, a UC San Diego professor of mechanical and aerospace engineering, has received the Presidential Award for Excellence in Science, Mathematics and Engineering Mentoring from the White House.
[…]